ArticleTargeted oncology2022

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study.

Assya Akli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.